Showing results (121-130 of 961) with videos related to
Sort By:
Pageof 97
Ejhaem|February 23, 2023
Immunotactoid glomerulopathy and chronic lymphocytic leukemia: The need for a multidisciplinary approachAngela Rago, Laura Pettorini, Alessandro Andriani, et al.Ejhaem|February 23, 2023
The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T-cell lymphomaHuanyu Gong, Bo Tang, Tiannv Li, et al.Ejhaem|February 23, 2023
Outcomes after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients with der(1;7)(q10;p10)Hiroki Mizumaki, Ken Ishiyama, Jun Aoki, et al.Ejhaem|February 23, 2023
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group databaseXuan Zheng, Bao-Lin Qu, Xin Liu, et al.Ejhaem|February 23, 2023
A phase III, randomised, double-blind, multi-national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuriaJun Ho Jang, Roberta Demichelis Gomez, Horia Bumbea, et al.Ejhaem|January 31, 2023
Bone marrow necrosis and fat embolism syndrome in sickle cell disease during COVID-19 infection treated successfully with sequential red cell and plasma exchangeSyed Rizvi, Muhammad Khakwani, Shivan Pancham, et al.Ejhaem|November 24, 2025
Moderate-Severe Thrombocytopenia Portends Poor Outcomes in Multiple MyelomaGrace M Ferri, Cenk Yildirim, Nhan V Do, et al.Ejhaem|November 28, 2025
Alternative 5-Azacitidine 5-Day 100 mg/m2 Dosage Shows Non-Inferiority to Classical Schedule for Myelodysplastic Neoplasm (MDS) and Chronic Myelomonocytic Leukaemia (CMML) TreatmentGerasimos Tsilimidos, Filipe Martins, Mariangela Costanza, et al.Ejhaem|November 3, 2025
T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation for Relapsed B-Cell Precursor Acute Lymphoblastic Leukemia After CAR-T TherapyNobuhisa Takahashi, Kazuhiro Mochizuki, Tomoko Waragai, et al.Ejhaem|October 27, 2025
Epcoritamab for Relapsed/Refractory EBV+ Post-Transplant Lymphoproliferative Disorder of DLBCL-TypeLi Yuan Chan, Simon O'Connor, Dima El-Sharkawi, et al.Pageof 97